Compounds > metformin

metformin and mk 2206

metformin has been researched along with mk 2206 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Hong, J; Hong, SE; Jang, SK; Jin, HO; Kim, JY; Lee, DH; Park, IC1

Other Studies

2 other study(ies) available for metformin and mk 2206

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin.
    Anticancer research, 2021, Volume: 41, Issue:7

    Topics: AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Heterocyclic Compounds, 3-Ring; Humans; Hypoglycemic Agents; Lung Neoplasms; Metformin; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt

2021